As of Jul 30
| +0.16 / +0.25%|
The 10 analysts offering 12-month price forecasts for Thoratec Corp have a median target of 58.50, with a high estimate of 63.50 and a low estimate of 43.00. The median estimate represents a -7.57% decrease from the last price of 63.29.
The current consensus among 13 polled investment analysts is to Hold stock in Thoratec Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.